The FPT and MPT were developed by the Ralston Group in 1998. The Ralston Group’s main purpose was to develop products that strengthen the pelvic floor muscles of women and thereby reduce the associated problems caused by weak pc muscles. The company now has four FDA registered medical devices including the standard FPT, small FPT, petite FPT and the MPT.
The Ralston Group contributes to the health and wellbeing of its customers in the quietness and privacy of their own homes. It gives us great satisfaction to know lives are changing in ways that only the user (and perhaps their partner) will ever know.
The standard Feminine Personal Trainer (FPT), was the first product to apply the principles of weight training to the pelvic floor muscles of women and has proven successful in relieving pain, as well as other symptoms associated with disorders of the pelvic floor.
As our presence grew with medical professionals, we began to have request for different sizes to accommodate the remaining estimated 10% of women that the standard did not quite fit. Therefore, we developed the small and petite versions of the FPT.
Over the next several years the FPT became established with numerous physical therapist and hospitals specializing in the treatment of pelvic floor dysfunction. As these caring professionals gained experience into the great potential for “weight lifting” for the pelvic floor they gave attention to the needs of their male patients recovering from surgery and other injuries. After receiving repeated requests for a “male device” we began development of what is now known as the MPT.
During the development phase of the MPT we combined our accumulated knowledge gained from the FPT work with the knowledge of anatomy professors, practicing physical therapist working with the pelvic floor and other medical professionals. The end result of our determined efforts became a medical first for men offering them the same rapid results as the women.
Although the MPT was developed in 2002, we decided to hold off release until adequate testing, experience and acceptance was gained through the medical arena before releasing it to the general public in 2004.